Sign in to view content

AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial

Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS

Video
Published 2020

Related

Is the Choroid Driving the Development of Cystoid Macular Edema in Eyes With Retinitis Pigmentosa?
David Sarraf, MD
Annual Meeting Talks
2019
Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
2019
Episode 199: Nov/Dec 2019 Retinal Physician Preview: New Pathways for Dry AMD
Jayanth Sridhar, MD
Member Podcasts
2019

Category: Hereditary Retinal Disease & Genetics

See more